Automated bone age estimation from routine abdominal CT using AI
Official title: Development and Evaluation of a Deep Learning-Based Model for Automated Osteoporosis Assessment Using CT Images
Run by Peking University People's Hospital · NCT07162168 · Data updated 2026-11-12
This project will try to use routine noncontrast abdominal CT scans and deep learning to estimate bone age in adults who had these scans for other medical reasons.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Peking University People's Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | September 1, 2024 |
| Main results expected | September 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | December 3, 2025 |
| Trial ID | NCT07162168 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 whose routine noncontrast abdominal CT scans fully include the proximal femur, were performed for non-orthopedic reasons, and have available demographic data, with no hip implants, tumors, severe deformity, or prior femoral fractures.
✕Probably not a fit
Patients without suitable CT images (for example, scans that do not include the proximal femur, have severe artifacts, or who have hip implants, bone tumors, major deformity, or prior femoral surgery) and pediatric or pregnant patients would not be expected to benefit from this analysis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This retrospective analysis uses existing noncontrast abdominal CT scans that include the proximal femur to train and test a deep-learning model to estimate bone age and signs of osteoporosis. Investigators will include adult scans taken for non-orthopedic indications and exclude images with implants, tumors, severe artifacts, or post-surgical changes. Demographic data such as chronological age and sex will be used alongside image features to compare model output to known patient information and any available bone-health measures. By repurposing routine imaging, the approach aims to provide bone-health information without additional radiation or dedicated scans.
Why it matters
Potential benefit: If successful, this approach could provide patients and clinicians with bone-age and osteoporosis risk information from existing CTs without extra scans or radiation, supporting earlier and more personalized bone-health care.
How similar studies have gone: Previous work using opportunistic CT and deep learning to detect osteoporosis and estimate bone density has shown promising results, though direct bone-age estimation from routine noncontrast abdominal CT is a relatively novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged over 18 years. * Underwent routine noncontrast abdominal CT scans. * CT scans fully included the proximal femur. * Scans were performed for non-orthopedic clinical indications. * Provided necessary demographic information (e.g., age, sex). Exclusion Criteria: * CT scans with poor image quality or severe artifacts that precluded accurate analysis. * History of hip surgery or presence of internal fixation devices. * Presence of bone tumors in the proximal femur. * Severe hip deformity or prior fractures affecting the proximal femur. * Pediatric patients or pregnant individuals (if applicable).
Where it's running
-
CT machine
Beijing, China Recruiting
Study contacts
- Study coordinator: hanwen Cheng, M.D
- Email: chenghanwen1998@126.com
- Phone: 86-19541080926
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
REMS testing for osteoporosis diagnosis and fracture risk in adults compared with DXA
This study tests whether REMS can diagnose osteoporosis and predict fracture risk in adults who are being evaluated for bone health, using DXA as the standard reference.
-
Evaluating bone density using ultrasound technology compared to DXA
This study is testing a new ultrasound method to see if it can accurately measure bone density in women aged 30-80 compared to the standard DXA scan.
-
Interferon-α Maintenance for Favorable-Risk AML
This study tests pegylated interferon alfa-2b as maintenance therapy to see if it helps keep favorable-risk AML in remission after initial treatment.
-
HLH after stem cell transplant: can routine blood tests flag risk in the next week?
This study tests whether changes in common blood tests and clinical data can predict HLH within seven days after a first allogeneic stem cell transplant.
-
MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC
This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.
-
ctDNA testing in newly diagnosed DLBCL or HGBL to predict treatment outcomes
This study checks if measuring circulating tumor DNA in blood after first-line therapy can predict whether the disease will stay away or come back in people with DLBCL or HGBL.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.